Navigation Links
Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/10/2009

Conference Call Scheduled for Today - Tuesday, March 10, 2009 at 4:30 p.m. Eastern Time

MOUNTAIN VIEW, Calif., March 10 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) reported today financial results for the fourth quarter and year ended December 31, 2008, and provided an update on its product development candidates. The net loss for the quarter and year ended December 31, 2008, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $15.0 million and $58.5 million, respectively, compared to a net loss of $13.2 million and $45.1 million in the comparable periods in 2007. Alexza had consolidated cash, cash equivalents and marketable securities (including investments held by Symphony Allegro) at December 31, 2008 of $58.9 million.

"In 2008, we made outstanding progress with AZ-004 (Staccato(R) loxapine), our lead program," said Thomas B. King, President and CEO of Alexza. "During the year, we initiated, fully enrolled and announced positive results in two Phase 3 clinical trials. This rapid progress has allowed us to be in the position to target an NDA filing for AZ-004 in early 2010. A majority of our focus and effort in 2009 will be on completing the balance of our NDA clinical program and finalizing the commercial manufacturing processes for AZ-004."

Financial Results - Periods Ended December 31, 2008 and 2007

GAAP operating expenses were $18.4 million and $79.2 million in the quarter and year ended December 31, 2008, compared to $17.4 million and $60.5 million for the comparable periods in 2007. The increases resulted primarily from increased spending on AZ-004 and AZ-104 as the Company continued development of these product candidates under the Symphony Allegro agreement, increased spending on AZ-003 with continu
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
2. Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
3. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
4. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
5. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
6. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
7. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
9. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
10. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
11. Alexza to Webcast Investor and Analyst Day Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Yisrayl Hawkins, Pastor and ... a letter pleading to let the children from other nations, ... allowed to come. Yisrayl says President Barack Obama is fighting ... the United States, and he wants to help him. ... from Guatemala, Honduras and El Salvador being treated as if ...
(Date:7/11/2014)... Netmail, a Canadian-based software ... Netmail Platform, today announced that it will be ... will be held in Washington’s George R. Brown ... show, Netmail will officially launch the latest release ... email security, archiving, encryption, eDiscovery, storage, monitoring into ...
(Date:7/10/2014)... Hopewell, NJ (PRWEB) July 11, 2014 ... announced it has performed the first procedure in a ... a catheter inserted in the leg. , During the ... Dr. Erol Veznedaroglu, an endovascular neurosurgeon, threaded a tiny ... up through the body and neck and into the ...
(Date:7/10/2014)... Ticketability.com has a wide array of tickets for ... for San Diego are being added to the inventory. The ... the newly added September 28 show is drawing a great ... to view the selection of discounted seats at Ticketability.com. ... available to the general public on July 18 at 10:00 ...
(Date:7/10/2014)... 2014 According to a new ... Platforms (Land, Airborne, Naval), Application (Software Defined Radios, ... Geography (North America, Asia-Pacific, Europe, the Middle East ... by MarketsandMarkets, the market is estimated to be ... register a CAGR of 5.56% to reach $39.52 ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 3Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 2Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 3Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4
... Celebration Honors City,s Exemplary Orgs., ... ... of Greater,Los Angeles will be honored as the Outstanding Volunteer Organization at,the ... Beverly Hilton Hotel., This award is given annually to a philanthropic ...
... system inhibitor irbesartan did not improve outcomes in ... fraction. -- There is not ... predominantly affects women and older patients; more research into ... NEW ORLEANS, Nov. 11 An angiotensin II,receptor blocker was no ...
... Study highlights:, -- Drug-eluting stents showed improved ... -- No excess adverse events were found ... Nov. 11 Drug-eluting stents,reduced the risk of ... with bare-metal stents in the largest observational comparison,researchers ...
... 11 A veteran medical,correspondent has received ... Achievement Award for excellence in medical and ... Calif., was honored for "his enterprising,in-depth reporting ... and cultural implications of cardiovascular medicine,providing invaluable ...
... changes that can lead to breast cancer could be one ... from the charity Breast Cancer Campaign to fill in one ... cancer experts in a recent study carried out by the ... thought to be involved in the early stages of breast ...
... that a walk of just fifteen minutes can reduce ... manage dependencies on nicotine and other drugs have previously ... shows that the same may be true for food ... chocolate eaters were asked to either complete a 15-minute ...
Cached Medicine News:Health News:American Red Cross of Greater Los Angeles Named Outstanding Volunteer Organization 2Health News:Heart Failure Patients With Normal Left Ventricular Ejection Fraction Don't Benefit From Treatment With Angiotensin II Receptor Blocker 2Health News:Heart Failure Patients With Normal Left Ventricular Ejection Fraction Don't Benefit From Treatment With Angiotensin II Receptor Blocker 3Health News:Drug-Eluting Stents Beat Bare Metal Stents in Diabetics 2Health News:Drug-Eluting Stents Beat Bare Metal Stents in Diabetics 3Health News:Drug-Eluting Stents Beat Bare Metal Stents in Diabetics 4Health News:New technique to study the genetics of breast cancer 2Health News:Brisk walk could help chocoholics stop snacking 2
(Date:7/10/2014)... , July 10, 2014  BC Technical, the ... MiE America , Inc., a leading provider of ... into a long-term agreement naming BC Technical as the ... MiE and BC Technical announced today ... to establish BC Technical as the service and systems ...
(Date:7/10/2014)...   LabStyle Innovations Corp . (OTCQB:DRIO), developer of ... appointment of Professor Richard B. Stone ... Directors. Prof. Stone brings over forty-five ... as an entrepreneur, venture capitalist public, company officer ... He currently serves on the board of directors ...
(Date:1/15/2014)... /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from ... China,s orthopedic instrument industry has seen ... rising from 3.28 billion yuan in 2006 to 9.85 ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... affordable, high-quality light guide cables work in ... provide optimal brightness during a number of ... give you the flexibility and ease-of-use necessary ... is fully-autoclavable so they can be easily ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
... Series Image Processing Video Camera is the ... specialties. This camera incorporates programmable head buttons ... enhancement, gain, and white balance to be ... and adjustable picture level control allow you ...
Medicine Products: